917 related articles for article (PubMed ID: 25301411)
1. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
2. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
4. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
6. Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease.
Su Y; Gu H; Weng D; Zhou Y; Li Q; Zhang F; Zhang Y; Shen L; Hu Y; Li H
Medicine (Baltimore); 2017 May; 96(18):e6617. PubMed ID: 28471958
[TBL] [Abstract][Full Text] [Related]
7. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
[TBL] [Abstract][Full Text] [Related]
8. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
9. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.
Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H
Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989
[No Abstract] [Full Text] [Related]
10. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
Scheja A; Akesson A; Hørslev-Petersen K
Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease.
La Montagna G; D'Angelo S; Valentini G
J Rheumatol; 2003 Oct; 30(10):2147-51. PubMed ID: 14528508
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
De Luca G; Bosello SL; Berardi G; Rucco M; Canestrari G; Correra M; Mirone L; Forni F; Di Mario C; Danza FM; Pirronti T; Ferraccioli G
Rheumatology (Oxford); 2015 Nov; 54(11):1991-9. PubMed ID: 26106211
[TBL] [Abstract][Full Text] [Related]
13. [Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia].
Tiev KP; Chatenoud L; Kettaneh A; Tolédano C; Bach JF; Cabane J
Rev Med Interne; 2009 Nov; 30(11):942-6. PubMed ID: 19577826
[TBL] [Abstract][Full Text] [Related]
14. Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.
Zachariae H; Heickendorff L; Bjerring P; Halkier-Sørensen L; Søndergaard K
Acta Derm Venereol; 1994 Sep; 74(5):368-70. PubMed ID: 7817674
[TBL] [Abstract][Full Text] [Related]
15. Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.
Scheja A; Wildt M; Wollheim FA; Akesson A; Saxne T
Rheumatology (Oxford); 2000 Oct; 39(10):1110-3. PubMed ID: 11035131
[TBL] [Abstract][Full Text] [Related]
16. Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.
Richardson C; Agrawal R; Lee J; Almagor O; Nelson R; Varga J; Cuttica MJ; Dematte JD; Chang RW; Hinchcliff ME
Semin Arthritis Rheum; 2016 Aug; 46(1):109-14. PubMed ID: 27033049
[TBL] [Abstract][Full Text] [Related]
17. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
[TBL] [Abstract][Full Text] [Related]
19. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
20. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
